Zobrazeno 1 - 6
of 6
pro vyhledávání: '"James Incalcaterra"'
Autor:
Nikhil G. Thaker, MD, David Boyce-Fappiano, MD, Matthew S. Ning, MD, Dario Pasalic, MD, Alexis Guzman, MBA, Grace Smith, MD, PhD, MPH, Emma B. Holliday, MD, James Incalcaterra, PhD, Adam S. Garden, MD, Simona F. Shaitelman, MD, G. Brandon Gunn, MD, C. David Fuller, MD, PhD, Pierre Blanchard, MD, Thomas W. Feeley, MD, Robert S. Kaplan, PhD, Steven J. Frank, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 374-382 (2021)
Purpose: In value-based health care delivery, radiation oncologists need to compare empiric costs of care delivery with advanced technologies, such as intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT). We used
Externí odkaz:
https://doaj.org/article/cf65fa9349e74f5c90a30784d33440e6
Autor:
Colin P.N. Dinney, Ashish M. Kamat, Thomas W. Feeley, Neema Navai, Janet Baack Kukreja, James Incalcaterra, Jay B. Shah, Marissa Wagner Mery
Publikováno v:
Journal of Urology. 199
Autor:
Daniel R. Gomez, Chidinma P. Anakwenze, James Incalcaterra, David Boyce-Fappiano, Todd A. Pezzi, Shane Mesko, Chad Tang, Zhongxing Liao, Steven J. Frank, Matthew S. Ning, Olsi Gjyshi, Nikhil G. Thaker, Alexis B. Guzman, Quynh-Nhu Nguyen, Nicholas D. Olivieri
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 103:E42-E43
Autor:
Stephen G. Swisher, Wayne L. Hofstetter, Arlene M. Correa, Heidi W. Albright, Caitlin C. Murphy, James Incalcaterra
Publikováno v:
Journal of Oncology Practice. 9:233-239
Purpose: Understanding the mechanisms and drivers of cost is a key component of improving the value of cancer care at both the system and patient level. Previous research on the cost of esophagectomy has established important postoperative drivers of
Autor:
Alexis B. Guzman, Christian C. Kolom, James Incalcaterra, Tiffany M. Jones, Monica DelValle-Garza, Yu-Ting Huang, Thomas W. Feeley
Publikováno v:
Journal of Clinical Oncology. 32:28-28
28 Background: Historically, hospital costs are based on a cost-to-charge ratio. The current cost system determines when a charge is filed and a bill is created, which can be days following the patient visit. This time lag between the patient visit a
Publikováno v:
Journal of Clinical Oncology. 31:262-262
262 Background: In 2010, the Institute for Cancer Care Innovation (ICCI) began measuring the true cost of cancer care delivery by following the patient treatment cycle from initial referral to survivorship or supportive care. The project was prompted